Senior insider sale
ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$373.5K
14.76K shares
What this filing means
HEYMAN RICHARD A. plans to sell 14.76K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $373.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/17/2026ACC: 0001974158-26-000018
Director
Since Feb 2026
14.76K
Shares to sell
$373.5K
Approx. market value
1.23K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Founders Shares
N/A
1/25/2020
1.23KTotal acquired1.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/25/2020 | Founders Shares N/A | 1.23K | — |
| Total | 1.23K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.23K
Market value
$32.9K
1/20/2026
—Completed
Units to sell
4.29K
Market value
$107.1K
1/9/2026
—Completed
Units to sell
8.02K
Market value
$200.7K
1/8/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.23K
Market value
$32.9K
2/17/2026
Total
Units
14.76K
Value
$373.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/20/2026 | 1.23K | $32.9K | — | Completed |
1/9/2026 | 4.29K | $107.1K | — | Completed |
1/8/2026 | 8.02K | $200.7K | — | Completed |
| Planned — Approximate Date | ||||
2/17/2026 | 1.23K | $32.9K | Nasdaq | Planned |
| Total | 14.76K | $373.5K | ||